Nyxoah SA - Ordinary Shares (NYXH)

1.4100
-0.0400 (-2.76%)
NASDAQ· Last Trade: Aug 5th, 6:46 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · August 5, 2026
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
By Nyxoah · Via GlobeNewswire · July 27, 2026
Nyxoah Announces Preliminary Results for the Second Quarter of 2026
Nyxoah Announces Preliminary Results for the Second Quarter of 2026
By Nyxoah · Via GlobeNewswire · July 7, 2026
Information on the total number of voting rights and shares
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · June 30, 2026
Publication relating to transparency notifications
        
By Nyxoah · Via GlobeNewswire · June 29, 2026
Nyxoah to Host Investor Day in New York on July 8, 2026
Nyxoah to Host Investor Day in New York on July 8, 2026
By Nyxoah · Via GlobeNewswire · June 23, 2026
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026
REGULATED INFORMATIONJune 19, 2026, 10:30pm CET / 4:30pm ET
By Nyxoah · Via GlobeNewswire · June 19, 2026
Publication relating to transparency notifications
        REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · June 17, 2026
Nyxoah Receives $15 Million from the European Investment Bank
Nyxoah Receives $15 Million from the European Investment Bank
By Nyxoah · Via GlobeNewswire · June 17, 2026
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
By Nyxoah · Via GlobeNewswire · June 15, 2026
Information on the total number of voting rights and shares
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · June 10, 2026
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch
By Nyxoah · Via GlobeNewswire · June 10, 2026
Nyxoah Announces Closing of Underwritten Public Offering
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · June 10, 2026
Nyxoah Announces Pricing of $95 Million Underwritten Public Offering
INSIDE INFORMATION
By Nyxoah · Via GlobeNewswire · June 5, 2026
Nyxoah Announces Proposed Offering of Ordinary Shares
INSIDE INFORMATION
By Nyxoah · Via GlobeNewswire · June 4, 2026
Nyxoah Enters New Chapter of Long Term Value Creation
INSIDE INFORMATION
By Nyxoah · Via GlobeNewswire · June 4, 2026
Information on the total number of voting rights and shares
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · May 20, 2026
Nyxoah Reports First Quarter 2026 Financial and Operating Results
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · May 12, 2026
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026
REGULATED INFORMATIONMay 8, 2026, 10:05pm CET / 4:05pm ET
By Nyxoah · Via GlobeNewswire · May 8, 2026
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference
By Nyxoah · Via GlobeNewswire · April 30, 2026
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026
By Nyxoah · Via GlobeNewswire · April 28, 2026
Publication relating to transparency notifications
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · March 20, 2026
Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · March 19, 2026
Publication relating to transparency notification
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · March 13, 2026
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
By Nyxoah · Via GlobeNewswire · March 11, 2026